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Abstract 
S-Palmitoylation is post-translational modification, which consists in the addition of a 
C16 acyl chain to cytosolic cysteines and which is unique amongst lipid modifications 
in that it is reversible. It can thus, as phosphorylation or ubiquitination, act as a 
switch. While palmitoylation of soluble proteins allows them to interact with 
membranes, the consequences of palmitoylation for transmembrane proteins are more 
enigmatic. We will briefly review the current knowledge regarding the enzymes 
responsible for palmitate addition and removal. We will then describe various 
observed consequences of membrane protein palmitoylation. We propose that the 
direct effects of palmitoylation on transmembrane proteins might however be limited 
to four non-mutually exclusive mechanistic consequences: alterations in the 
conformation of transmembrane domains, association with specific membrane 
domains, controlled interactions with other proteins and controlled interplay with 
other post-translational modifications.  
 
Keywords: membrane proteins, protein conformation, rafts, protein complexes, 
DHHC, palmitoylation 
 
Abbreviations: Endoplasmic Reticulum: ER; transmembrane domain: TMD;  
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Introduction 
S-palmitoylation is a post-translational modification of proteins, which consists in the 
attachment of a saturated C16 fatty acid chain to specific cysteines via a thio-ester 
bond [1]. As opposed to other lipid modifications, S-palmitoylation is reversible. 
Since S-palmitoylation impacts on protein function, as discussed below, its 
reversibility allows regulation, or fine-tuning, of protein function, in a manner similar 
to protein phosphorylation or ubiquitination.  
Recent large-scale profiling studies indicated that the number of S-palmitoylated 
proteins varies from ≈50 in yeast [2] to several hundreds in mammals [3, 4]. 
Palmitoylation of soluble proteins allows their controlled association with 
membranes, trafficking and domain localization, as shown for the small Rat sarcoma 
(Ras) GTPase at the cell surface [5] or phospholipid scramblase 3-mediated apoptosis 
at the mitochondria [6].  Palmitoylation however also occurs on transmembrane 
proteins, which will be the focus of this review. These proteins are by definition 
membrane anchored and thus the effect of attaching an acyl chain to them is less 
intuitive, specially considering that acylation frequently occurs on cysteines adjacent 
to, or even within, the transmembrane domain (TMD). The cytosolic domains of 
membrane proteins can also undergo S-palmitoylation. 
The list of membrane proteins that undergo palmitoylation is ever growing and spans 
a bewildering variety of key cellular functions. Amongst the studied palmitoylated 
proteins are cell adhesion molecules [7] such as integrins [8] and claudins [9], 
tetraspanins such as CD81 [10], CD36 [11] and CD151 [12], many G-protein coupled 
receptors (GCPRs) such as rhodopsin [13], a great variety of channels and 
transporters (epithelial sodium channel [14], aquaporins [15], BK channel [16], 
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dopamine or glutamate transporters,…), multiple receptors (acetylcholine, 
cannabinoid, opiod, ß-adrenergic, dopamine, prostacyclin, estrogen, progesterone, 
androgen,  NMDA, AMPA receptors,… [17, 18] [19] [20]; [21]), receptor ligands 
such as Fas Ligand [22], but also enzymes such as ß and γ-secretases [23, 24], the E3 
ligase gp78 [25], the protein disulfide isomerase TMX [26], chaperones (calnexin 
[27]) or numerous viral glycoproteins (influenza hemaglutinin, vesicular stomatitis 
virus G protein, SARS CoV S protein,… for review see [28]). In each study 
documenting protein palmitoylation, a cellular and/or functional consequence was 
observed such as altered signaling capacity [6, 8, 20], reduced activity [29], modified 
trafficking [30, 31], differential stability [13, 32]. Many of the reported effects are 
however likely to be secondary consequence. The direct, mechanistic, consequences 
of palmitoylation of membrane proteins are however difficult to identify. Four 
consequences, that we will review here through selected examples and which could be 
either direct or early events, have however emerged over time and are not mutually 
exclusive: alterations in protein conformation, association with specific membrane 
domains, controlled interactions with other proteins and controlled interplay with 
other post-translational modifications (Fig. 1). 
 
Palmitoyltransferases and thioesterases 
Palmitate is available in the cell in the form of palmitoyl-CoA at nanomolar 
concentrations [33]. Unless palmitoyl-CoA is enriched in specific membrane 
microdomains [34], cellular concentrations are insufficient for spontaneous 
palmitoylation of proteins to occur. S-palmitoylation is thus mostly enzymatic and 
mediated by a family of DHHC (Asp-His-His-Cys) motif containing 
palmitoyltransferases, of which there are 23 in humans [1], some 20 in worms and 
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flies, and 7 in yeast [2]. It is at present largely unclear why cells express multiple 
DHHC proteins and what the substrate specificity of these enzymes is [35, 36]. So far 
no real consensus sequence surrounding the cysteine residues has been identified [2] 
even though some relatively successful prediction algorithms are available (for 
example: http://csspalm.biocuckoo.org/).  
DHHC proteins are membrane proteins that span the bilayer at least 4 times and 
harbor the conserved DHHC cysteine-rich catalytic domain on the cytosolic face. 
They differ in their subcellular localization: many localize to the early secretory 
pathway (endoplasmic reticulum (ER) and Golgi) while others can be found at the 
plasma membrane or in endocytic vesicles [37]. DHHC proteins greatly vary in their 
N-terminal and C-terminal cytosolic domains which may carry protein-protein 
interaction domains such as ankyrin repeats in DHHC13 and DHHC17 or a predicted 
src Homology 3 domain in DHHC6. These extensions are likely involved in their 
localization and in substrate specificity [38, 39] since the DHHC-containing catalytic 
domain is not sufficient to convey specificity [39, 40].  
What determines the specificity of a given DHHC protein for its substrates is 
currently unclear. In yeast, it was proposed that certain DHHC proteins preferentially 
modify soluble proteins, while others appear to require an additional modification, 
such as myristoylation or prenylation [2, 41]. Interestingly, Swf1 showed preference 
towards transmembrane proteins and cysteines that are in close proximity to TMDs 
[2]. In humans, it was found that certain substrates can be modified by a restricted set 
of DHHC proteins, for example the SNAP receptor (SNARE) protein SNAP25 can be 
modified on its 4 cysteines by DHHC3, DHHC7 and DHHC17 [42]. In contrast the 
transmembrane ER chaperone calnexin is exclusively palmitoylated on its 
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juxtamembranous double cysteine motif by DHHC6 [27], while integrin α6ß4 is 
specifically modified by DHHC3 [8].  
So far little information is available regarding the regulation of DHHC proteins, both 
in terms of expression and activity. It has been shown, in yeast and in mammals, that 
palmitoylation of Ras requires the formation of a complex between the 
palmitoyltransferase Erf2 (DHHC9 in mammals) and the interacting protein Erf4 
(GCP16 in mammals) [43, 44]). Interaction of DHHC proteins with co-factors might 
be more wide spread. Also they might undergo specific post-translational 
modifications in response to specific stimuli or stress conditions. In this context, it is 
worth mentioning that a large-scale proteomic analysis of palmitoylated proteins 
suggested that DHHC5, DHHC6 and DHHC8 are themselves palmitoylated [4] but 
these hits were not further validated, nor were the consequences of palmitoylation 
addressed. 
In the cytosol, S-palmitoylation is reversed by acyl protein thioesterases (APTs) of 
which three have so far been identified, APT1, APT2 and APT1-like [45, 46]. Only a 
handful of studies have addressed their implication in the palmitoylation-
depalmitoylation cycles of proteins. APT1 was shown to depalmitoylate Gα proteins 
[47, 48], APT2 to depalmitoylate growth-associated protein-43 [46, 49], both were 
found to depalmitoylate Ras [49] and APT1 and APT1-like were found to 
depalmitoylate the calcium-activated large potassium channel (BK) [50]. 
Altering the activity or expression levels of APTs clearly constitutes an effective 
method of regulating protein palmitoylation levels. For example, based on a 
functional screen to identify microRNAs involved in dendritic spine morphogenesis, 
microRNA-138 was found to be highly enriched and to regulate expression of APT1 
in dendrites, thereby controlling palmitoylation of Gα13 [48]. 
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Effects of palmitoylation on the conformation of transmembrane proteins 
S-palmitoylation frequently occurs on cysteins adjacent to TMDs. Since this clearly 
does not have a membrane anchoring function, it was proposed early on that 
palmitoylation of juxtamembranous cysteines could induce tilting of TMDs [51]. 
Joseph and Nagaraj showed that palmitoylation of a hydrophobic synthetic peptide 
reconstituted into liposomes affected the orientation of the TMD. This concept has 
remained attractive and has been utilized to explain the effect of palmitoylation on the 
behavior of several membrane proteins [52-55]. The effect of palmitoylation on the 
conformation of a transmembrane protein was however not explicitly addressed. We 
have approached the issue when studying the palmitoylation of lipoprotein receptor-
related protein 6 (LRP6) [30]. LRP6 has a well-established role in canonical Wnt 
signaling, a key pathway in early embryonic development as well as cancer. Upon 
binding of Wnt proteins to their receptors of the Frizzled family, a ternary Wnt-
Frizzled-LRP6 is formed and transmits the signal across the membrane. LRP6 is a 
type I membrane protein with two juxtamembrane palmitoylation sites [30]. Upon 
mutation of the palmitoylation sites, LRP6 is recognized by the ER quality control 
and retained. LRP6 has a 23 residue long TMD, i.e. 2 residues longer than the vast 
majority of single pass membrane proteins. Since the ER membrane has been 
proposed to be thinner than the plasma membrane, a long TMD might lead to a 
hydrophobic mismatch. Tilting of the TMD through palmitoylation, as proposed by 
Joseph and Nagaraj [51], would reduce the effective hydrophobic length. To test this 
possibility, we shortened of the TMD of LRP6. In the absence of palmitoylation, 
shortening relieved the ER retention, whereas in the presence of palmitoylation 
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shortening led to ER retention, consistent with an effect of palmitoylation of the 
conformation of the TMD [30]. 
Interestingly, ER retention of palmitoylation-deficient LRP6 was due to 
ubiquitination of a lysine residue in the close proximity of the TMD [30]. Mutation of 
this lysine relieved ER retention. The protein was then properly targeted to the plasma 
membrane and competent for Wnt signaling. Intriguingly however, mutation of the 
juxtamembranous lysine on the WT background, while not affecting plasma 
membrane targeting, drastically reduced Wnt signaling [30]. Thus both in the ER and 
at the plasma membrane there appears to be a cross-talk between palmitoylation and 
ubiquitination of LRP6 (see below).  
 
Association with membrane domains 
A major focus of studies on the palmitoylation of membrane proteins has been the 
role of this modification in promoting their association with lipid rafts –cholesterol 
and sphingolipid rich membrane domains [56]. Palmitoylation of many proteins will 
indeed promote their association with lipid rafts  (for review see [57]). A recent 
example is the death receptor 4 that undergoes DHHC3-mediated palmitoylation [58] 
on 3 cytosolic cysteines, thus allowing its proper targeting to the plasma membrane 
and its association with lipid rafts, which was found to be required for ligand-induced 
cell death [59].  Palmitoylation-dependent raft association has also been shown 
recently for ß-secretase BACE1 [23], cannabinoid receptor [19], influenza virus M2 
protein [60] and Close Homolog of Adhesion Molecule L1 (CHL1) [50]. Exceptions 
do exist however such as the G protein of vesicular stomatitis virus and the transferrin 
receptor which are both palmitoylated on three sites yet localize to non-raft domains 
(for review see [57]), or the anthrax toxin receptor Tumor endothelial marker 8 
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(TEM8), for which palmitoylation was actually found to negatively regulate raft 
association [32]. 
The ability of palmitoylation to target proteins to specific membrane domains might 
however not be restricted to lipid rafts. It was indeed found that palmitoylation of the 
chaperone calnexin and the thioredoxin-related transmembrane protein TMX, two 
transmembrane proteins of the ER, is required for their targeting to specific ER 
domains, the ER-mitochondrial interaction sites [26]. Palmitoylation of calnexin also 
appears to be necessary for its localization to the nuclear envelope [27]. 
Palmitoylation of the ER E3 ligase gp78, involved in particular in the down regulation 
of HMGCoA reductase, was recently found to regulate the localization of the protein 
to the peripheral ER [25]. Although detergent-resistant ER domain have been 
observed [61], the very low cholesterol content of this compartment suggests that 
these domains must have different assembly mechanisms, and thus do not fulfill the 
definition of lipid rafts. 
By controlling the association of membrane proteins with specific membrane 
domains/compartments, palmitoylation can bring together, or alternatively segregate, 
proteins that have the ability to interact under specific circumstances. For example, 
Neurotensin receptor-1, a G-protein coupled receptor (GPCR) implicated in breast 
cancer progression is palmitoylated, allowing it to interact with cholesterol-rich 
domains where its downstream Gα protein resides [62].  Thus in the absence of 
palmitoylation signaling is reduced. The opposite situation was observed for the 
anthrax toxin receptor TEM8, where palmitoylation negatively regulates raft-
association, thus sequestering the receptor away from its E3 ubiquitin ligase Cbl [32]. 
In the absence of palmitoylation, TEM8 is prematurely ubiquitinated at the cell 
surface and targeted to lysosomes. 
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How palmitoylation affect rafts association of proteins is unclear. It could be due to 
the affinity of palmitate for specific lipids or lipid domains. This is suggested by 
studies of different isoforms of Ras that are or not palmitoylated [63]. Palmitoylation 
was shown to promote association with cholesterol-rich nanoclusters, while non-
palmitoylated Ras was excluded from these domains [64]. In the case of 
transmembrane proteins, modified raft-association could however also be due to the 
effect of palmitoylation on the conformation of TMDs. Indeed, since cholesterol rich 
domains are though to be thicker than other parts of the membrane due to the presence 
of cholesterol, modification of TMD tilting through palmitoylation might affect the 
effective length of the hydrophobic segments leading to protein partitioning through 
membrane thickness. 
 
Effect on protein-protein association 
Palmitoylation of membrane proteins also appears to affect their ability to associate 
with other, soluble or transmembrane, proteins. One striking example is provided by 
the so-called tetraspanin webs, large protein complexes that include multiple 
palmitoylated tetraspanin proteins [12, 65-67] as well as palmitoylated integrin 
subunits such as α3, α6 and β4 [8, 68, 69]. Palmitoylation may occur on multiple sites 
as shown for KAI1, a member of tetraspanin family that inhibits migration and 
invasion of metastatic prostate cancer cells, and is palmitoylated on 5 cysteines [65]. 
Palmitoylation regulates interactions between tetraspanins and between tetraspanins 
and integrins, and this can occur in rather sophisticated ways as recently shown for 
CD151 for which palmitoylation differentially affects its interaction with α3β1 vs. 
α6β4 integrins [12]. 
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We have recently found that palmitoylation of the ER chaperone calnexin is required 
for the formation of a super-complex that includes the ER translocon, the ribosome, 
the oligosaccharyltransferase and calnexin, and is stabilized by polymerized actin 
[27]. This complex allows newly synthesized proteins to be sequentially handled by 
the enzymes and chaperones that allow it to reach its native state. 
Palmitoylation can however also negatively affect protein multimerization as was 
shown for the neural cell adhesion molecule (NCAM) 140 that is essential for axonal 
growth. DHHC7-dependent palmitoylation of NCAM140 [70] leads to raft 
association, but negatively regulates the hemophilic dimerization of extracellular 
NCAM domains in cis [71]. Interestingly, neuritogenesis requires interplay between 
NCAMs and Fibroblast Growth Factor receptor signaling, and FGF leads to the 
activation of DHHC7 that in turn enhances NCAM palmitoylation [70] further 
promoting axonal growth [72]. 
Palmitoylation may also control the interaction of membrane proteins with 
cytoplasmic proteins as shown for the Cation-dependent Mannose-6-phosphate 
receptor (CD-M6PR), a type I transmembrane protein, responsible for sorting of 
newly synthesized acid-hydrolases from the trans-Golgi etwork to endosomes. Once 
the M6PR has delivered its hydrolases to late endosomes, it is recycled back to the 
Golgi for re-utilization. This step depends on palmitoylation of M6PR [73] by 
DHHC15 [74]. More specifically it was found that palmitoylation allows the 
interaction of the cytosolic tail of M6PR with the retromer complex [74]. 
Palmitoylation is also important for the function of a wide array of GPCRs, one of the 
largest classes of transmembrane proteins, involved in variety of signaling pathways. 
A well-characterized example is the β-2-adrenergic receptor (β-2AR) which triggers 
activation of an adenylate cyclase, production of cyclic adenosine monophosphate 
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(cAMP) and activation of protein kinase A (PKA). In the late 1980s it was reported 
that β-2AR is palmitoylated and that this is important to prevent uncontrolled receptor 
desensitization and thereby loss of signaling [75]. Recently it was demonstrated that 
palmitoylation enables β-2AR to interact with cAMP degradation enzyme 
phosphodiesterase 4D as well as with the adaptor protein β-arrestin 2, which is 
required for agonist-induced receptor internalization [18]. Thus by interfering with 
desensitization, the lack of β-2AR palmitoylation leads to enhanced receptor-induced 
PKA activities in the cytoplasm. Consistent with these conclusions, palmitoylation-
deficient β-2AR was found to be phosphorylated even in the absence of stimulus [76, 
77]. Interestingly, stimulation with the agonist has also been proposed to induce 
depalmitoylation of the receptor [78]. A full understanding of how cycles of 
palmitoylation-depalmitoylation regulated β-2AR signaling will require further 
inquiry. 
 
Interplay between palmitoylation and other post-translational modifications 
As just illustrated by β-2AR, there are interplays between palmitoylation and other 
post-translational modifications on the same protein, ge erally in close proximity of 
the palmitoylation sites. As mentioned earlier, we found that palmitoylation deficient 
LRP6 undergoes ubiquitination in the ER of juxtamembranous lysine residues [30]. 
Similarly we found that palmitoylation deficient TEM8 undergoes ubiquitination at 
the cell surface, again in the vicinity of the palmitoylation sites, resulting in 
destabilization of TEM8 and its premature degradation [32]. Premature degradation of 
palmitoylation deficient mutants has been observed for a variety of proteins both in 
tissue cultures cells such as for CCR5 [79, 80] but also in knock-in mice for 
rhodopsin [13]. Interestingly, rhodopsin destabilization was not apparent in tissue 
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culture studies but clearly evident in mice. Also in yeast, palmitoylation of the 
SNARE protein (see below) Tlg1 was found to prevent ubiquitination and degradation 
[52]. Although palmitoylation is generally found to stabilize proteins, the reverse has 
also been observed as for the E3 ubiquitin ER ligase gp78 [25]. 
Interplay also occurs between palmitoylation and post-translational modifications 
other than ubiquitination. This is the case for the large conductance calcium-activated 
potassium (BK) channels, and especially those containing the stress-regulated exon 
(STREX) splice variant [16, 81, 82]. BKs are six-spanning membrane proteins with a 
long cytosolic tail, corresponding to the site of insertion of the STREX domain. 
Palmitoylation was found to occur on three sites in the cytoplasmic loop separating 
TMD1 and 2 [50] and on 2 sites in the STREX domain [82]. Modification of the 
cytoplasmic loop is mediated by DHHC22 and DHHC23 and reversed by APT1 and 
APT1L, and the palmitoylation-depalmitoylation cycle is required to tune expression 
of BK channels, but does not affect activity [50, 83]. Modification of the STREX 
domain is mediated by DHHC3, DHHC5, DHHC7, DHHC9 and DHHC17 and also 
reversed by APT1 and APT1L [50, 82, 83]. Palmitoylation brings the STREX domain 
to the membrane, this alters the conformation of the cha nel, renders it insensitive to 
phosphorylation by PKC and thus to its inhibitory effect [83]. Depalmitoylation or 
phosphorylation by PKA leads to disassembly of the STREX domain from the 
membrane, rendering it sensitive to PKC inhibition [83]. 
Although it is not relevant to transmembrane proteins, it is worth mentioning that 
palmitoylation of soluble proteins may require a prior, irreversible, lipid modification 
such as prenylation. This is the case for Ras, which undergoes farnesylation shortly 
after synthesis, allowing it to weakly interact with the ER and the Golgi [63]. 
Subsequent palmitoylation of specific Ras isoforms on the Golgi leads to stable 
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membrane association and vesicular traffic-mediated transport to the plasma 
membrane [84], whereas depalmitoylation leads to non-vesicular transport of Ras 
back to the Golgi [85]. 
 
Concluding remarks 
S-Palmitoylation has been known for many decades. With the identification of both 
the enzymes that mediated the modification and those that reverse it, as well as the 
advent of new technologies to determine cellular palmitomes, the field has however 
entered a new era and the pace of discoveries has hugely accelerated. Some 
mechanistic consequences have already emerged, as reviewed here, but many open 
questions remain, such as the importance of palmitoylation-depalmitoylation cycles 
and the global consequences of palmitoylation at the cellular and organism levels.  
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FIGURE LEGEND 
Figure 1: Consequences of the palmitoylation of membrane proteins. 
Palmitoylation of proteins in the proximity of their transmembrane domain has been 
proposed to 1) regulate in a positive, but also possibly negative, manner their 
association with lipid rafts, 2) to affect the conformation of their transmembrane 
domain such as tilting it, 3) to prevent ubiquitination of lysines in proximity of the 
palmitoylation site, 4) to promote the formation of protein complexes. These various 
effects are not mutually exclusive and might actually explain one another, for 
example tilting of the transmembrane domain could promote its association with a 
specific domain which could sequester it away from its E3 ubiquitin ligase or/and 
promotes its association with proteins present in this domain. 
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